Stifel Financial Corp 9 Meters Biopharma, Inc. Transaction History

Stifel Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.21 - $0.32 $2,100 - $3,200	10,000 Added 7.14%	150,000 $32,000
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $6,500 - $16,000	25,000 Added 21.74%	140,000 $37,000
Q3 2021 Nov 15, 2021	BUY	$1.03 - $1.41 $118,450 - $162,150	115,000 New	115,000 $150,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.